PubMed

The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group.

[No authors listed]

Ann Intern Med. 1995 Apr 15;122(8):561-8.PMID: 7887548 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group.

[No authors listed]

N Engl J Med. 1993 Sep 30;329(14):977-86.PMID: 8366922 [PubMed - indexed for MEDLINE]Related articlesFree article

Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.

[No authors listed]

Ophthalmology. 1995 Apr;102(4):647-61.PMID: 7724182 [PubMed - indexed for MEDLINE]Related articles

Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.

[No authors listed]

Ann Intern Med. 1998 Apr 1;128(7):517-23.PMID: 9518395 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.

[No authors listed]

Arch Ophthalmol. 1995 Jan;113(1):36-51.PMID: 7826293 [PubMed - indexed for MEDLINE]Related articles

The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT).

[No authors listed]

Diabetologia. 1998 Apr;41(4):416-23.PMID: 9562345 [PubMed - indexed for MEDLINE]Related articlesFree article

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M.

Diabetes Res Clin Pract. 1995 May;28(2):103-17.PMID: 7587918 [PubMed - indexed for MEDLINE]Related articles

Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.

[No authors listed]

J Pediatr. 1994 Aug;125(2):177-88.PMID: 8040759 [PubMed - indexed for MEDLINE]Related articles

Implementation of treatment protocols in the Diabetes Control and Complications Trial.

[No authors listed]

Diabetes Care. 1995 Mar;18(3):361-76.PMID: 7555480 [PubMed - indexed for MEDLINE]Related articles

Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial.

[No authors listed]

Ann Intern Med. 1996 Feb 15;124(4):379-88.PMID: 8554246 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial.

[No authors listed]

Ann Neurol. 1995 Dec;38(6):869-80.PMID: 8526459 [PubMed - indexed for MEDLINE]Related articles

Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group.

[No authors listed]

Kidney Int. 1995 Jun;47(6):1703-20.PMID: 7643540 [PubMed - indexed for MEDLINE]Related articles

Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.

Shichiri M, Kishikawa H, Ohkubo Y, Wake N.

Diabetes Care. 2000 Apr;23 Suppl 2:B21-9.PMID: 10860187 [PubMed - indexed for MEDLINE]Related articles

The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.

[No authors listed]

Diabetes. 1996 Oct;45(10):1289-98.PMID: 8826962 [PubMed - indexed for MEDLINE]Related articles

Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.

White NH, Sun W, Cleary PA, Danis RP, Davis MD, Hainsworth DP, Hubbard LD, Lachin JM, Nathan DM.

Arch Ophthalmol. 2008 Dec;126(12):1707-15.PMID: 19064853 [PubMed - indexed for MEDLINE]Related articlesFree article

Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.

Martin CL, Albers J, Herman WH, Cleary P, Waberski B, Greene DA, Stevens MJ, Feldman EL; DCCT/EDIC Research Group.

Diabetes Care. 2006 Feb;29(2):340-4.PMID: 16443884 [PubMed - indexed for MEDLINE]Related articlesFree article

The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.

[No authors listed]

Diabetes. 1995 Aug;44(8):968-83.PMID: 7622004 [PubMed - indexed for MEDLINE]Related articles

Metaanalysis of the effects of intensive glycemic control on late complications of type I diabetes mellitus.

Wang PH, Lau J, Chalmers TC.

Online J Curr Clin Trials. 1993 May 21;Doc No 60:[5023 words; 37 paragraphs].PMID: 8306007 [PubMed - indexed for MEDLINE]Related articles

Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. Microalbuminuria Collaborative Study Group, United Kingdom.

[No authors listed]

BMJ. 1995 Oct 14;311(7011):973-7.PMID: 7580637 [PubMed - indexed for MEDLINE]Related articlesFree article

Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes.

Genuth S.

Endocr Pract. 2006 Jan-Feb;12 Suppl 1:34-41. Review.PMID: 16627378 [PubMed - indexed for MEDLINE]Related articles